ABOUT ELITE
PRODUCTS
PIPELINE
- Generic
- Branded
TECHNOLOGY
INVESTOR RELATIONS

HOME | CAREERS | CONTACT | NEWS |

Skip to content

About Elite
Products
Pipeline
- Generic
- Branded
Technology
Investor Relations

Press Releases

Select:

Mar 17, 2016 Elite Announces U.S. FDA Priority Review Designation for SequestOx™ NDA

Feb 09, 2016 Elite Pharmaceuticals, Inc. Reports Strong Growth for Third Quarter of Fiscal Year 2016

Feb 05, 2016 Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss 3rd Quarter 2016 Financial Results on February 10, 2016

Jan 13, 2016 FDA Approves Waiver of NDA Filing Fee for Elite Pharmaceuticals

Jan 13, 2016 Nasrat Hakim Named Chairman of Board of Directors for Elite Pharmaceuticals

Nov 09, 2015 Elite Pharmaceuticals, Inc. Reports Strong Growth for Second Quarter of Fiscal Year 2016

Nov 05, 2015 Elite Pharmaceuticals, Inc. to Host Conference Call and Webcast to Discuss 2nd Quarter 2016 Financial Results on November 10, 2015

Oct 21, 2015 Elite Pharmaceuticals Announces Positive Top-Line Results From a Pivotal Phase 3 Study for Abuse-Deterrent Opioid ELI-200

Sep 02, 2015 Elite Pharmaceuticals to Present at the 17th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th

Aug 10, 2015 Elite Pharmaceuticals, Inc. Reports Record Revenues for First Quarter of Fiscal Year 2016

10 11 12 13 14 15 16 17 18 19 20

<< < > >>

Site Map | Privacy | Terms Of Use

Copyright © Elite Pharmaceuticals Inc. | All Rights Reserved.

ART™: Abuse-Resistant Technology for a safer healthier you.

Resize Viewer - Reduce

Resize Viewer - Expand